Wednesday, August 31, 2016

BRIEF-Amarin randomizes final patient into reduce-it cardiovascular outcomes study of Vascepa

* Amarin randomizes final patient into reduce-it

cardiovascular outcomes study of Vascepa

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)